Skip to main content
Clinical Trials/NCT05263427
NCT05263427
Completed
Not Applicable

Maternal-Fetal Monitoring by Connected Abdominal Patch - MOMA

University Hospital, Lille1 site in 1 country60 target enrollmentAugust 31, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstetrical Complications
Sponsor
University Hospital, Lille
Enrollment
60
Locations
1
Primary Endpoint
Fetal heart rate with the TOCONAUTE
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

During a previous clinical trial (RCF-abdo: 2018-A01194-51), trans-abdominal signals were collected in 90 patients at the maternity Jeanne de Flandre. This database allowed us to develop a new medical device able to measure in real time and continuously the fetal heart rate and the uterine contractions.

The goal here is to assess the performance of the device in real situation during labour.

This study will be carried out in the maternity labor ward in CHU Lille, France.

The TOCONAUTE will be placed on the mother's abdomen to capture fetal and maternal heart rate as well as the uterine contractions in parallel of the cardiotocograph.

For each of the participants, the TOCONAUTE will remain on the mother's abdomen till childbirth. This procedure will not affect the usual care of the patient.

Registry
clinicaltrials.gov
Start Date
August 31, 2022
End Date
November 3, 2023
Last Updated
4 months ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Sponsor
University Hospital, Lille
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pregnant woman in labor
  • Singleton
  • Cephalic presentation

Exclusion Criteria

  • Hospitalisation for a medical termination of pregnancy
  • Death in utero
  • Multiple pregnancy

Outcomes

Primary Outcomes

Fetal heart rate with the TOCONAUTE

Time Frame: 1 year

The fetal heart rate from the our device will be averaged on 3 beats and resampled at 4Hz to be comparable to the fetal heart rate from the cardiotocograph. Both of the signals will be resynchronized and compared sample by sample with a Pearson's correlation test. Measure of the fetal heart rate with the TOCONAUTE compared to the measure of the fetal heart rate with a cardiotocograph.

Secondary Outcomes

  • Maternal heart rate with the TOCONAUTE(1 year)
  • Fetal stress index (Heart rate variability index reflecting parasympathetic fluctuation)(1 year)
  • Uterine contractions with the TOCONAUTE according to the different phase of labor.(1 year)
  • Fetal heart rate with the TOCONAUTE according to the different phase of labor.(1 year)

Study Sites (1)

Loading locations...

Similar Trials